Global Cholesterol Testing Devices Market 2018-2022

The global cholesterol testing devices market is forecasted to grow to more than USD 5.4 billion by 2022. Wondering how to make the most of this booming industry? Technavio’s comprehensive industry research report presents a detailed overview that will allow you to take full advantage of the opportunities available to you. This study provides an in-depth analysis of the market by end-user type (hospitals, home healthcare, and others), and by region (the Americas, EMEA, and APAC). It also examines the competitive landscape and key market players that include Abaxis, Abbott, and ACON Laboratories.

Want to know what type of information to expect from this report? The infographic below contains a selection of facts about cholesterol test procedure and devices. Find out more below!

The global cholesterol testing devices market is expected to expand at a CAGR of almost 7% during the forecast period

Cholesterol testing devices industry growth is expected to accelerate over the next five years, driven by countries around the world. While the Americas will drive the largest growth of over more than 40%, EMEA and APAC are also expected to make significant contributions to the incremental growth in the forecast period. The Americas held the largest market share in 2017, followed by EMEA and APAC. However, APAC region is forecasted to generate a higher incremental growth than EMEA at the end of the forecast period. Technavio’s cholesterol testing devices industry analysis reveals promising markets around the world.

Want a bigger picture? Try a free sample of this report now!

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Hospitals are the leading segment in the market by end-user with a revenue share of over 48%

The leading segment in the market by end-user are hospitals, and this segment is expected to continue their dominance over the forecast period. This segment is followed by home healthcare and others. The growing occurrence of chronic and lifestyle-based disorders require accurate cholesterol test results, which is likely to contribute to the growth of the market. The rising rates of cardiovascular disease across the globe is a leading cause of death and cholesterol test procedure plays a vital role in diagnosing such disorders at an early stage.

Get more value with Technavio’s subscription platform! Gain easy access to all Technavio’s reports, along with on-demand services.      Start your 14-day FREE trial

Abaxis, Abbott, and ACON Laboratories are among leading vendors in the cholesterol testing devices market

As the cholesterol testing devices industry continues to grow, there is greater emphasis being placed on cholesterol test results by medical practitioners. According to CDC, over 750,000 hospitalizations take place every year and around 130,000 deaths take place annually due to cardiovascular disease. The number of incidences of cardiovascular disease is on the rising owing to factors such as urbanization, diabetes, alcohol and tobacco consumption. The growing cases of cardiovascular disorders calls for increased adoption of the best cholesterol test procedure and devices to achieve accurate cholesterol test results. Many international and regional vendors are vying for their share of the market, and players must differentiate themselves to gain vital traction over their competitors.

This report offers a complete analysis of several companies, including:

• Abaxis
• Abbott
• ACON Laboratories
• Akers Biosciences
• F. Hoffmann-La Roche

Want to dial in on a specific region or segment? We can help! Our analysts can customize this report to meet your requirements.  

   Get in touch